Ascent Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $896K | Buy |
10,264
+899
| +10% | +$78.5K | 0.03% | 355 |
|
|
2025
Q1 | $640K | Buy |
9,365
+676
| +8% | +$46.2K | 0.03% | 401 |
|
|
2024
Q4 | $676K | Buy |
8,689
+739
| +9% | +$57.5K | 0.05% | 327 |
|
|
2024
Q3 | $533K | Buy |
7,950
+583
| +8% | +$39.1K | 0.04% | 366 |
|
|
2024
Q2 | $835K | Buy |
7,367
+1,072
| +17% | +$122K | 0.07% | 293 |
|
|
2024
Q1 | $873K | Buy |
6,295
+222
| +4% | +$30.8K | 0.08% | 292 |
|
|
2023
Q4 | $719K | Buy |
6,073
+1,047
| +21% | +$124K | 0.07% | 296 |
|
|
2023
Q3 | $464K | Buy |
5,026
+71
| +1% | +$6.56K | 0.05% | 325 |
|
|
2023
Q2 | $546K | Sell |
4,955
-1,474
| -23% | -$162K | 0.06% | 302 |
|
|
2023
Q1 | $747K | Buy |
6,429
+1,530
| +31% | +$178K | 0.08% | 265 |
|
|
2022
Q4 | $555K | Buy |
4,899
+121
| +3% | +$13.7K | 0.07% | 290 |
|
|
2022
Q3 | $577K | Buy |
4,778
+98
| +2% | +$11.8K | 0.07% | 270 |
|
|
2022
Q2 | $384K | Buy |
4,680
+364
| +8% | +$29.9K | 0.05% | 350 |
|
|
2022
Q1 | $552K | Buy |
4,316
+584
| +16% | +$74.7K | 0.06% | 282 |
|
|
2021
Q4 | $394K | Buy |
+3,732
| New | +$394K | 0.05% | 340 |
|